| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2003 | 2007 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
apolipoprotein A4 | 0.582 | 0.577 | 5.5E-06 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2009 | ||||||||
|
F11 receptor | 0.542 | 0.731 | 1.8E-05 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2007 | ||||||||
|
kallikrein 1 | 0.533 | 0.769 | 1.5E-04 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2006 | ||||||||
|
proprotein convertase subtilisin/kexin type 2 | 0.663 | 0.462 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
phosphodiesterase 5A | 0.513 | 0.731 | 1.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neuropeptide FF-amide peptide precursor | 0.821 | 0.154 | 3.6E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
calcium/calmodulin dependent protein kinase II alpha | 0.612 | 0.538 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
S100 calcium binding protein A8 | 0.430 | 0.962 | 0.14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
transcription factor A, mitochondrial | 0.529 | 0.731 | 0.17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
tachykinin receptor 3 | 0.553 | 0.769 | 1.8E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
acyl-CoA synthetase long chain family member 4 | 0.561 | 0.769 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
acyl-CoA synthetase long chain family member 3 | 0.674 | 0.538 | 3.5E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 |